09.45-10.00
Time-restricted feeding provides limited microglial immunometabolic improvements in diet-induced obese rats
Chun-Xia Yi

10.00-10.15
A novel in vitro bioassay shows increased sensitivity to glucocorticoids in individuals with obesity compared with lean individuals
Robin Lengton

10.15-10.30
Impact of Sleeve Gastrectomy on Hepatic and Cardiac Postprandial Fatty Acid Metabolism 14 Days After Surgery
Christophe Noll

10.30-10.45
Weight loss in obese mice rapidly normalizes metabolic parameters but does not completely restore immune cell landscape in metabolic organs
Joost Lambooij

10.45-11.00
Relation between adipose tissue distribution, cognitive decline and structural brain changes in patients with cardiovascular disease: The SMART-MR study
Ritobrata Bhattacharya

11.00-11.15
The effect of intermittent or continous calorie-restricted diet on body composition and energy expenditure in type 2 diabetes
Karlijn Geurts

09.45-10.00
Mental Health Changes After 4 Months of Weight Loss Treatment with the GLP-1 Analogue Liraglutide 3.0 mg
Susanne Kuckuck

10.00-10.15
Implementation of person reported outcome measurement (PROM) in daily clinical care of a type 1 diabetes clinic: reducing the burden of questionnaire-overload
Per Winterdijk

10.15-10.30
Picture living with diabetes: A photovoice study of young adults’ efforts in making diabetes care fit into their lives
Anka van Gastel

10.30-10.45
Limited health literacy and numeracy among adults with diabetes on intensive insulin treatment
Lisa den Brok

10.45-11.00
Outcomes of a 14- week rehabilitation program for individuals with diabetes experiencing prolonged self-care difficulties: A prospective observational cohort study
Arne Kooistra

11.00-11.15
Socioeconomic Determinants of Shiftwork: A Cross-sectional Analysis from the CLSA and Hoorn Studies
Tucker Reed

09.45-10.00
Targeting Methylglyoxal: a novel approach to improve vascular function in diabetes
Luisa Wensky

10.00-10.15
Fructose-induced formation of advanced glycation endproducts is independent of methylglyoxal
Michelle van Oeteren

10.15-10.30
Arterial stiffness is associated with worse beta cell function: The Maastricht Study
Jie Shen

10.30-10.45
“Magnesium Supplementation did not Reduce Serum Calciprotein Crystallization and Arterial Stiffness in Individuals with Type 2 Diabetes: a Randomized Trial”
Romain Meer

10.45-11.00
Differential effects in atherogenic dyslipidemia by liver steatosis and liver fibrosis in patients with type 2 diabetes
Laura Konings

11.00-11.15
Renal Functional Reserve Predicts GFR Response to Empagliflozin in Overweight Patients with Type 2 Diabetes: Insights from the RENALIS and RACELINES Clinical Trials
Marcel Muskiet

09.45-10.00
Effect of timed exercise interventions on patientreported outcome measures: A systematic review
Mirey Karavetian

10.00-10.15
Cardiometabolic response to HIIT training in a prediabetic population
Marie Lepitre

10.15-10.30
Restoring 24-hour substrate rhythmicity to improve glycemic control by timing of lifestyle factors: exploring patient perspectives on time restricted exercise
Pam LeBlanc

10.30-10.45
The Impact of Acute AM vs. PM Exercise on Nocturnal Energy and Substrate Metabolism in Individuals at Risk of Developing Type 2 Diabetes
Marit Kotte

10.45-11.00
The Effect of Timing of Physical Exercise on Glycemia: A Systematic Review and Metaanalysis of Human Intervention Studies – TIMED-consortium
Romy Slebe

14.00-14.15
Organ-specific dietary fatty acid partitioning in individuals with prediabetes after 12 weeks of high-intensity interval training
Sophie Hogan-Lamarre

14.15-14.30
Effect of intermittent fasting interventions on patient-reported outcomes: a systematic review
Mirey Karavetian

14.30-14.45
Engaging Patient Partners in Fundamental and Population Health Research for Diabetes Prevention in the TIMED Consortium
Matt Larsen

14.45-15.00
Effects of the first European Food Prescription Program for people with type 2 diabetes and low socioeconomic status: a randomised controlled pilot trial
Carmen Dietvorst

15.00-15.15
Cost-effectiveness of a 3-month intensive combined lifestyle intervention for older adults with obesity and type 2 diabetes
Robert Memelink

14.00-14.15
Individual variability in Liver Fat Changes after Acute Exercise and Associations with Fatty Acid Fluxes in Prediabetes
Elisa Le Roux

14.15-14.30
Mild hypoxia exposure alters metabolic pathways in HepG2 cells
Geng Li

14.30-14.45
Sex-specific development of MASH and glucose intolerance in a murine MASH Model
Sabine Daemen

14.45-15.00
Liver fat content is not elevated in people with type 1 diabetes – The Maastricht Study
Nefeli Dimitropoulou

15.00-15.15
Differential Associations Between Liver Fat and Postprandial Glucose Levels Across Sex and Menopausal Status; The Maastricht Study
Esther Kemper

15.15-15.30
Development of 2D and 3D models of primary human hepatocytes for studying the role of protein glycans in MASLD-MASH progression
Qianyue Zhang

14.00-14.15
Unravel Diabetes Pathogenesis Markers of microvascular dysfunction increased in the heart of diabetic patients
Amber Korn

14.15-14.30
The impact of gestational diabetes mellitus on pancreatic development in mice
Yuyao Xiang

14.30-14.45
Nocturnal carbohydrate oxidation is elevated in type 2 diabetes, and may be driven by fasting insulin and triglyceride levels
Soraya de Kam

14.45-15.00
Circulating rhythmic metabolites and type 2 diabetes risk: Evidence for causality from the Canadian Longitudinal Study on Aging
Divya Joshi

15.00-15.15
Beyond the marginal pool: hypoglycaemia stimulates erythropoiesis, in part mediated through adrenaline, in people with and without type 1 diabetes
Ilyas Mustafajev

15.15-15.30
Interaction between pancreatic volume, pancreatic fat infiltration, and beta cell mass
Sevilay Tokgöz

14.00-14.15
Case Radboudumc
Prof. Cees Tack

14.15-14.30
Case ZGT
Prof. Goos Laverman

14.30-15.00
Panel discussion

09.00-09.15
Development and evaluation of the web-based tool: The Nutri+ questionnaire for assessing habitual dietary intake in type 2 diabetes
Lotte Peters

09.15-09.30
Mapping Standard Care for Pregestational Diabetes in the Netherlands: A Healthcare Providers Survey
Veronika Duwel

09.30-09:45
Developing evidence-based antenatal metformin doses
Caroline Dibbets

09.45-10:00
Effectiveness and safety of combining sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies
Jan de Leijer

10.00-10.15
Reproducibility of Placebo-Corrected Albuminuria Responses to Dapagliflozin in Type 2 Diabetes and Chronic Kidney Disease: A Bayesian N-of- 1 Trial Approach
Jelle Beernink

10.15-10.30
A preliminary analysis of the OMED2-study to examine the change in HbA1c-levels after deprescribing glucose-lowering medication in overtreated older adults with type 2 diabetes
Charlotte Andriessen

09.00-09.15
Inflammation and Diabetes Low-grade inflammation does not mediate the associations between n-3 polyunsaturated fatty acids and CVD in participants with and without type 2 diabetes: The Maastricht Study
Elena Tore

09.15-09.30
Timing and intensity of physical activity in relation to inflammation in a middle-aged population
Jeroen Van Der Velde

09.30-09.45
Adrenaline at levels observed during hypoglycaemia acutely affects immune cell subsets and monocyte function in people with and without type 1 diabetes
Marijn Hendriksz

09.45-10.00
Dietary Methylglyoxal Prevents Vascular and Metabolic Dysfunction in High-Fat Diet-Induced Diabetic Mice
Philippe Vangrieken

10.00-10.15
Increased cardiovascular risk and mortality during the active phase of a diabetic foot ulcer
Mark Zwerus

10.15-10.30
Skeletal muscle transcriptomic analysis reveals upregulated oxidative metabolism and downregulated inflammatory pathways after pharmacological inhibition of fructose metabolism
Evi Koene

09.00-09.15
Survival Following Diabetic Foot Ulcers and Lower Extremity Amputations
Anne Merijn Eligh

09.15-09.30
Hoorn Early HFpEF study: definitions matter
Maroucha van den Berg

09.30-09.45
Risk of Procedure-Related Complications in a Single-Centre Cohort of Islet-After-Kidney Transplant Recipients
Roxanna Hauck

09.45-10.00
Type 1 Diabetes and Dementia Risk; Findings from a National Registry-Based Matched Cohort Study
Milena Jancev

10.00-10.15
Type 2 diabetes and risk of clinically relevant depressive symptoms: role of microvascular dysfunction, neurodegeneration, inflammation, AGEs and arterial stiffness – The Maastricht Study
Indra Steens

09.00-09.15
Prolonged β2-agonist treatment enhances muscle-specific glucose uptake in individuals with overweight and obesity: a randomized placebo-controlled trial
Pip van Lier

09.15-09.30
Development of a minimal invasive methodology for diabetyping using the traditional and a modified Oral Glucose Tolerance Test to personalize type 2 (pre)diabetes treatment
Suzan Wopereis

09.30-09.45
Highs, lows and inflammatory flows: The link between glycaemic variability and inflammation in people with diabetes
Eleen Schupp

09.45-10.00
CGM metrics as indicators of graft function in islet transplant recipients
Willemijn de Vos

10.00-10.15
Glucose variability in diabetes: an inflammatory trigger for macrophages?
Manon Dumont

09.00-09.15
Higher fecal butyrate is associated with lower time in euglycemic range in a cohort of 398 individuals with type 1 diabetes
Lente Blok

09.15-09.30
Deciphering inflammatory cues from the microbiome: Bacterial membrane vesicles produced in response to prebiotic and antibiotic intake
Jari Verbunt

09.30-09.45
Investigation of Fecal and Plasma Methylglyoxal Levels and Their Association with the Gut Microbiome in Individuals with Type 1 Diabetes
Oluwatomisono Akinrimisi

09.45-10.00
Fiber mixture alters real-time intestinal gas kinetics in lean individuals and individuals with overweight/ obesity
Gillian Larik

10.00-10.15
Personalized fibre mixtures reduce HOMA-IR in individuals with prediabetes and overweight/obesity
Nouhaila Hamari